Cofounder and Chief Technology Officer
Abhishek Trigunait, a seasoned Life Sciences executive driven by positive patient outcomes, brings over two decades of experience in digital strategy, data and AI technologies, managing large-scale portfolios, multi-million-dollar budgets, and teams across the globe. He has successfully delivered globally recognized, compliant and award-winning solutions across the drug development and delivery value chain, leveraged by both Top 10 and emerging pharma customers, enabling tens of thousands of users across 100+ countries. Recognized as a visionary architect of AI-driven digital ecosystems, he combines deep technical expertise in life sciences-specific AI/ML frameworks with proven success in scaling compliant, patient-centric innovation across global markets
LinkedIn
Featured in top journals for innovative solutions bridging technology and commercial excellence
Cambridge, MA- Disrupting the healthcare Consulting landscape, Improzo Inc. is rapidly gaining traction with its innovative approach that tackles modern challenges and prioritizes patients.
Founded with a Mission- Born from the desire to improve patient access by addressing rising healthcare costs, Improzo partners with pharmaceutical and Medical device Companies.
The firm’s ability to navigate complex regulatory environments, combined with its focus on leveraging technology for greater efficiency, positions it as a valuable partner for organizations seeking to thrive in a competitive market.
Through its work with leading pharmaceutical companies & medical devices, Improzo uniquely blends the power of combining deep industry expertise with cutting-edge tools
The founders of Improzo Inc., Jeremy Carter and Abhishek Trigunait, bring exceptional expertise and leadership to the firm. Carter, a veteran in the life sciences industry with over two decades of experience, has guided high-performance teams across sales and delivery functions globally, including in North America, Europe, Latin America, and Asia-Pacific.